Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
Homepage
About Us
About Kybora
Leadership Team
Success Stories
Our Global Presence
Social Responsibility
Services
M&A
Licensing
Fundraising
Strategic Advisory
News Feed
Contact
English
English
中文
KYBORA Successfully Helps STADA License Xlucane to Bausch Health
February 26, 2020
Comments are off for this post.
News
About the author
.
Drcom Content Editor
Recent blog post
.
KYBORA Welcomes Vladyslava Bab’yak as an Analyst
Posted: 1 week ago
Podcast: Healthcare Insights by KYBORA
Posted: 2 weeks ago
RODIM Reaches Key Milestones in 2024 Through Strategic Partnership with KYBORA and BPEACE
Posted: 3 weeks ago
Top 10 Challenges Facing CEOs of Biotech Startups and Small/Mid-Sized Biotechs in a Post-2022 World
Posted: 4 weeks ago
KYBORA Welcomes Erik Heinnickel as Senior Director of Operations
Posted: 1 month ago
Tags
.
#biopharma Licensing
Announcement
Bausch Health
biopharma
biotechnology
China
Conference
Corporate
globalhealthcare
healthtech
Kybora Team
LIcensing
March 2020
mergersandacquisitions
News
Priority List
Stada license
TYPE & ENTER:
Close
